These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9273505)

  • 21. Controversies on the prevention of diabetic nephropathy.
    Chiarelli F; Verrotti A; Basciani F; di Ricco L; Sabatino G; Morgese G
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dyslipidemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy].
    Martínez-Castelao A; Ramos R; González MT; Castiñeiras MJ
    Nefrologia; 2002; 22 Suppl 1():51-8. PubMed ID: 11987671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nephropathy: an overview for daily practice].
    Pittrow D; Wittchen HU; Bramlage P; Dikow R; Kirch W; Lehnert H; Ritz E
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():39-44. PubMed ID: 14732949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Microalbuminuria in diabetes: setting the points for treatment].
    Lehnert H; Klose S; Lobmann R; Zehnder D
    MMW Fortschr Med; 2006 May; 148(21):28-30, 33; quiz 34. PubMed ID: 16796185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand.
    Buranakitjaroen P; Deerochanawong C; Bunnag P
    J Med Assoc Thai; 2005 Nov; 88(11):1624-9. PubMed ID: 16471111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diabetic nephropathy - Treatment].
    Plum J; Hader C
    Dtsch Med Wochenschr; 2002 Jun; 127(24):1328-32. PubMed ID: 12063666
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus.
    Rossing P
    Diabet Med; 1998 Nov; 15(11):900-19. PubMed ID: 9827844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controversies on the pathogenesis of diabetic angiopathy: which treatment for normotensive adolescents with microalbuminuria and type 1 diabetes?
    Danne T; Kordonouri O
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():347-63. PubMed ID: 9642665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diabetic patient with renal insufficiency.
    Vanhille P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():67-72. PubMed ID: 10922976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interventional possibilities in diabetic nephropathy].
    Jungmann E
    Fortschr Med; 1993 Oct; 111(29):451-2. PubMed ID: 8258420
    [No Abstract]   [Full Text] [Related]  

  • 33. Early diagnosis of diabetic nephropathy.
    Bilous RW
    Diabetes Metab Rev; 1996 Oct; 12(3):243-53. PubMed ID: 8959387
    [No Abstract]   [Full Text] [Related]  

  • 34. [Diagnosis, implication, prevention and treatment of microalbuminuria].
    Schmieder RE; Bramlage P
    Dtsch Med Wochenschr; 2012 Jul; 137(27):1409-16; quiz 1417-8. PubMed ID: 22736183
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diagnosis and therapy of diabetic nephropathy].
    Hasslacher C
    Fortschr Med; 1990 Dec; 108(36):694-7. PubMed ID: 2086427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Microalbuminuria and early diagnosis of diabetic nephropathy].
    Podgórski G; Kołaczyński J
    Pol Tyg Lek; 1991 Oct 7-21; 46(40-42):783-6. PubMed ID: 1669159
    [No Abstract]   [Full Text] [Related]  

  • 37. [Course and treatment of diabetic nephropathy].
    van Gaal L; Moeremans M; de Leeuw I; Bekaert J
    Ned Tijdschr Geneeskd; 1986 Feb; 130(8):348-51. PubMed ID: 3960177
    [No Abstract]   [Full Text] [Related]  

  • 38. Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment.
    Ayodele OE; Alebiosu CO; Salako BL
    J Natl Med Assoc; 2004 Nov; 96(11):1445-54. PubMed ID: 15586648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progress on diagnosis and therapy of diabetic nephropathy].
    Hotta N; Kakuta N
    Nihon Naika Gakkai Zasshi; 1992 Jan; 81(1):31-7. PubMed ID: 1348264
    [No Abstract]   [Full Text] [Related]  

  • 40. [Nephropathy and hypertension in type II diabetes].
    Ritz E; Bergis K; Strojek K; Keller C
    Med Klin (Munich); 1997 Jul; 92(7):421-5. PubMed ID: 9324628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.